Multigene testing for breast cancer risk assessment: an illusion of added clinical value
Chin Clin Oncol
.
2017 Apr;6(2):15.
doi: 10.21037/cco.2017.03.02.
Authors
Anna Sokolenko
1
,
Evgeny Imyanitov
2
Affiliations
1
N.N. Petrov Institute of Oncology, St.-Petersburg 197758, Russia; St.-Petersburg Pediatric Medical University, St.-Petersburg 194100, Russia.
2
N.N. Petrov Institute of Oncology, St.-Petersburg 197758, Russia; St.-Petersburg Pediatric Medical University, St.-Petersburg 194100, Russia; I.I. Mechnikov North-Western Medical University, St.-Petersburg 191015, Russia; St.-Petersburg State University, St.-Petersburg 199034, Russia. evgeny@imyanitov.spb.ru.
PMID:
28482668
DOI:
10.21037/cco.2017.03.02
No abstract available
Publication types
Editorial
Comment
MeSH terms
Breast
Breast Neoplasms / genetics
Genetic Testing*
Humans
Illusions*
Risk Assessment